[308 Pages Report] The global bronchopulmonary dysplasia treatment market is expected to be worth US$ 346 million in 2022 and US$ 661.7 million by 2032, growing at a CAGR of 6.1% during the forecast period. The increasing cases of bronchopulmonary dysplasia, as well as the rise in premature births, can be attributed to the growth of the …
Continue reading “Bronchopulmonary Dysplasia Treatment Market value of US$ 346 Million in 2022”